{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:22:43Z","timestamp":1792264963021,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZC20233356"],"award-info":[{"award-number":["GZC20233356"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["v3.60"],"award-info":[{"award-number":["v3.60"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","award":["W0172"],"award-info":[{"award-number":["W0172"]}],"id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573031"],"award-info":[{"award-number":["82573031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ebiom.2026.106280","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:06:31Z","timestamp":1777935991000},"page":"106280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["TCF1+CD4+ T cells and microglia co-orchestrate tertiary lymphoid structures to enhance prognosis and immunotherapy in non-small cell lung cancer with brain metastases"],"prefix":"10.1016","volume":"127","author":[{"given":"Qian","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengqiu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaicheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2026.106280_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-018-0055-y","article-title":"Brain metastases","volume":"5","author":"Achrol","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ebiom.2026.106280_bib2","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/annonc\/mdz207","article-title":"Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer","volume":"30","author":"Kudo","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ebiom.2026.106280_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41698-025-00901-0","article-title":"Immunotherapy in lung cancer brain metastases","volume":"9","author":"Paisana","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.ebiom.2026.106280_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00262-023-03599-w","article-title":"Coordination of anti-CTLA-4 with whole-brain radiation therapy decreases tumor burden during treatment in a novel syngeneic model of lung cancer brain metastasis","volume":"73","author":"Blethen","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ebiom.2026.106280_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1470-2045(20)30111-X","article-title":"Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial","volume":"21","author":"Goldberg","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ebiom.2026.106280_bib6","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.21.00174","article-title":"Five-year outcomes with pembrolizumab versus chemotherapy for metastatic non-small-cell lung cancer with PD-L1 tumor proportion score >\/= 50","volume":"39","author":"Reck","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2026.106280_bib7","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.19.03136","article-title":"Updated analysis from KEYNOTE-189: pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic nonsquamous non-small-cell lung cancer","volume":"38","author":"Gadgeel","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2026.106280_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2026.106280_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105154","article-title":"T cell exhaustion initiates tertiary lymphoid structures and turbocharges cancer-immunity cycle","volume":"104","author":"Lin","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2026.106280_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Sautes-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ebiom.2026.106280_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105003","article-title":"Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer","volume":"101","author":"Di Modugno","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2026.106280_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.106030","article-title":"Mature tertiary lymphoid structures support B cell-mediated antitumour immunity and are disrupted by neoadjuvant therapy in rectal cancer: a multicentre, retrospective study","volume":"122","author":"Tian","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2026.106280_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2026.106280_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64980-y","article-title":"The impact of tertiary lymphoid structures on tumor prognosis and the immune microenvironment in non-small cell lung cancer","volume":"14","author":"Weng","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2026.106280_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-025-01754-7","article-title":"Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities","volume":"18","author":"Deng","year":"2025","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ebiom.2026.106280_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41591-023-02673-1","article-title":"Multiomic spatial landscape of innate immune cells at human central nervous system borders","volume":"30","author":"Sankowski","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2026.106280_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnves.2024.100005","article-title":"The molecular and immune microenvironmental landscape of brain metastases: implications for novel treatment options","volume":"1","author":"Li","year":"2025","journal-title":"Cell Investigation"},{"key":"10.1016\/j.ebiom.2026.106280_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/imm.13581","article-title":"BDNF is a prognostic biomarker involved in immune infiltration of lung adenocarcinoma and is associated with brain metastasis","volume":"168","author":"Yu","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.ebiom.2026.106280_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100063","article-title":"Standardized pathology screening of mature tertiary lymphoid structures in cancers","volume":"103","author":"Vanhersecke","year":"2023","journal-title":"Lab Invest"},{"key":"10.1016\/j.ebiom.2026.106280_bib20","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1038\/s41467-024-46873-w","article-title":"Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer","volume":"15","author":"Kasikova","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2026.106280_bib21","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41416-021-01307-y","article-title":"Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer","volume":"124","author":"Rakaee","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ebiom.2026.106280_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009232","article-title":"Density of tertiary lymphoid structures predicts clinical outcome in breast cancer brain metastasis","volume":"12","author":"Zhao","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ebiom.2026.106280_bib23","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/0008-5472.CAN-17-1987","article-title":"Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma","volume":"78","author":"Silina","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.ebiom.2026.106280_bib24","doi-asserted-by":"crossref","first-page":"979","DOI":"10.12688\/f1000research.73600.1","article-title":"Doublet identification in single-cell sequencing data using scDblFinder","volume":"10","author":"Germain","year":"2021","journal-title":"F1000Res"},{"key":"10.1016\/j.ebiom.2026.106280_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009449","article-title":"Inhibitory fcgamma receptor deletion enhances CD8 T cell stemness increasing anti-PD-1 therapy responsiveness against glioblastoma","volume":"12","author":"Ku","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ebiom.2026.106280_bib26","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2026.106280_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad672","article-title":"aPEAR: an R package for autonomous visualization of pathway enrichment networks","volume":"39","author":"Kerseviciute","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ebiom.2026.106280_bib28","article-title":"Intracarotid cancer cell injection to produce mouse models of brain metastasis","volume":"8","author":"Zhang","year":"2017","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ebiom.2026.106280_bib29","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/cmi.2017.13","article-title":"Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy","volume":"14","author":"Tang","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ebiom.2026.106280_bib30","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1200\/JCO.2016.69.7144","article-title":"Management of brain metastases in tyrosine kinase inhibitor-naive epidermal growth factor receptor-mutant non-small-cell lung cancer: a retrospective multi-institutional analysis","volume":"35","author":"Magnuson","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2026.106280_bib31","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1200\/JCO.2014.56.6661","article-title":"Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer","volume":"33","author":"Liang","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ebiom.2026.106280_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ebiom.2026.106280_bib33","doi-asserted-by":"crossref","first-page":"E1738","DOI":"10.1073\/pnas.1525528113","article-title":"New tools for studying microglia in the mouse and human CNS","volume":"113","author":"Bennett","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2026.106280_bib34","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nri2832","article-title":"New insights into the development of lymphoid tissues","volume":"10","author":"van de Pavert","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2026.106280_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh0380","article-title":"Stem-like CD4(+) T cells in perivascular tertiary lymphoid structures sustain autoimmune vasculitis","volume":"15","author":"Sato","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2026.106280_bib36","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41590-023-01682-z","article-title":"CD4(+) T cell immunity is dependent on an intrinsic stem-like program","volume":"25","author":"Zou","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2026.106280_bib37","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1038\/s41467-018-05412-0","article-title":"Regulation of T cell afferent lymphatic migration by targeting LTbetaR-mediated non-classical NFkappaB signaling","volume":"9","author":"Piao","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2026.106280_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","article-title":"Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ebiom.2026.106280_bib39","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302465","article-title":"CXCR4: from B-cell development to B cell-mediated diseases","volume":"7","author":"Giorgiutti","year":"2024","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.ebiom.2026.106280_bib40","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1038\/s41467-021-24347-7","article-title":"Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma","volume":"12","author":"van Hooren","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2026.106280_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.724739","article-title":"Tertiary lymphoid structures in the central nervous system: implications for glioblastoma","volume":"12","author":"van de Walle","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2026.106280_bib42","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.molmed.2024.10.014","article-title":"Tertiary lymphoid structures in the central nervous system","volume":"31","author":"Yang","year":"2025","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ebiom.2026.106280_bib43","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.21873\/anticanres.17184","article-title":"Tertiary lymphoid structures in brain metastases of lung cancer: prognostic significance and correlation with clinical outcomes","volume":"44","author":"Nohira","year":"2024","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ebiom.2026.106280_bib44","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-neuro-113023-103045","article-title":"Meningeal lymphatics in central nervous system diseases","volume":"47","author":"Salvador","year":"2024","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.ebiom.2026.106280_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","article-title":"Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives","volume":"17","author":"Lin","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ebiom.2026.106280_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021067","article-title":"The TGF-beta family in glioblastoma","volume":"25","author":"Golan-Cancela","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2026.106280_bib47","article-title":"Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ebiom.2026.106280_bib48","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ccell.2023.03.015","article-title":"Lymphocyte networks are dynamic cellular communities in the immunoregulatory landscape of lung adenocarcinoma","volume":"41","author":"Gaglia","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ebiom.2026.106280_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adk2612","article-title":"cGAS-activated endothelial cell-T cell cross-talk initiates tertiary lymphoid structure formation","volume":"9","author":"Zhao","year":"2024","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ebiom.2026.106280_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1504220","article-title":"High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC","volume":"15","author":"Forde","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2026.106280_bib51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.celrep.2018.03.086","article-title":"Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images","volume":"23","author":"Saltz","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2026.106280_bib52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/neuonc\/noae167","article-title":"Toll-like receptor agonists promote the formation of tertiary lymphoid structure and improve anti-glioma immunity","volume":"27","author":"Shen","year":"2025","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ebiom.2026.106280_bib53","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1073\/pnas.1503315112","article-title":"IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs","volume":"112","author":"Barone","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2026.106280_bib54","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1084\/jem.20131737","article-title":"IL-17-induced CXCL12 recruits B cells and induces follicle formation in BALT in the absence of differentiated FDCs","volume":"211","author":"Fleige","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2026.106280_bib55","article-title":"Enhanced formation of tertiary lymphoid structures shapes the anti-tumor microenvironment in hepatocellular carcinoma after FOLFOX-HAIC therapy","volume":"6","author":"Xing","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ebiom.2026.106280_bib56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejca.2021.01.036","article-title":"Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy","volume":"148","author":"Groeneveld","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ebiom.2026.106280_bib57","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1084\/jem.20181216","article-title":"Type I interferon induces CXCL13 to support ectopic germinal center formation","volume":"216","author":"Denton","year":"2019","journal-title":"J Exp Med"},{"key":"10.1016\/j.ebiom.2026.106280_bib58","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/infdis\/jix233","article-title":"Aberrant humoral immune responses in neurosyphilis: CXCL13\/CXCR5 play a pivotal role for B-Cell recruitment to the cerebrospinal fluid","volume":"216","author":"Yu","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106280_bib59","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/art.21062","article-title":"Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome","volume":"52","author":"Barone","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ebiom.2026.106280_bib60","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4143\/crt.2016.215","article-title":"Predictive value of tertiary lymphoid structures assessed by high endothelial venule counts in the neoadjuvant setting of triple-negative breast cancer","volume":"49","author":"Song","year":"2017","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.ebiom.2026.106280_bib61","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41420-025-02420-0","article-title":"CXCL12 alone is enough to reprogram normal fibroblasts into cancer-associated fibroblasts","volume":"11","author":"Ma","year":"2025","journal-title":"Cell Death Discov"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426001623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426001623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:32:23Z","timestamp":1783193543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426001623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":61,"alternative-id":["S2352396426001623"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106280","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TCF1+CD4+ T cells and microglia co-orchestrate tertiary lymphoid structures to enhance prognosis and immunotherapy in non-small cell lung cancer with brain metastases","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106280"}}